The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease

Experimental Neurology

Volumn 146, Issue 2, 1997, Pages 458-465

  Aksenov, M Y ^a   Aksenova, M V ^a   Payne, R M ^c   Smith, C D ^b   Markesbery, W R ^a,b   Carney, J M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE BB; ISOENZYME; MESSENGER RNA; MITOCHONDRIAL ENZYME;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NIEMANN PICK DISEASE; PRIORITY JOURNAL;

EID: 0031213840     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6550     Document Type: Article

References (50)

1. 1. Aalto, T. K., and K. O. Raivio. 1993. Nucleotide depletion due to reactive oxygen metabolites in endothelial cells: Effects of antioxidanys and 3-aminobenzamide. Pediatr. Res. 34: 572-576.
2. 2. Auchus, A. P., R. C. Green, and C. B. Nemeroff. 1994. Cortical and subcortical neuropeptides in Alzheimer's disease. Neurobiol. Aging 15: 589-595.
3. 3. Bessman, S. P., and P. G. Geiger. 1981. Transport of energy in muscle: the phosphorylcreatine shuttle. Science 211: 448-452.
4. 4. Bessman, S. P. 1985. The creatine-creatine phosphate energy shutle. Annu. Rev. Biochem. 54: 831.
5. 5. Beal, M. F. 1994. Energy oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle. Neurobiol. Aging 15: 171-174.
6. 6. Burbaeva, G. S., M. V. Aksenova, and V. I. Bibikova. 1987. The activity of CK BB in certain brain structures of schizophrenic patients and normal controls. Zur Neiropathol. Psichiatr. 87: 1024-1028.
7. 7. Burbaeva, G. S., M. V. Aksenova, I. G. Makarenko, and O. O. Kalinenko. 1990. The decrease of CK BB level in brain of mental patients (complex immunochemical and immunohistochemical study). Zur Neiropatol. Psichiatr. 90: 49-52.
8. 8. Burbaeva, G. S., M. V. Aksenova, and I. G. Makarenko. 1992. Decreased level of creatine kinase BB in the frontal cortex of Alzheimer patients. Dementia 3: 91-94.
9. 9. Burmistrov, S. O., O. P. Mashek, and A. M. Kotin. 1992. The action of acute alcoholic intoxication on the antioxidant system and creatine kinase activity in the brain of rat embryos. Eksp. Klin. Farmakol. 55: 54-56.
10. 10. Butterfield, D. A., K. Hensley, M. Harris, M. P. Mattson, and J. M. Carney. 1994. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200: 710-715.
11. 11. Chromzynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
12. 12. Friedman, D. L., and M. B. Perryman. 1991. Compartmentation of multiple forms of creatine kinase in the distal nephron of rat kidney. J. Biol. Chem. 266: 22404-22410.
13. 13. Friedman, D. L., and R. Roberts. 1994. Compartmentation of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: evidence for a creatine phosphate energy shuttle in adult rat brain. J. Comp. Neurol. 343: 500-511.
14. 14. Frolich, L., and P. Riederer. 1995. Free radical mechanisms in dementia of Alzheimer's type and the potential for antioxidative treatment. Arzheim.-Forsch. 45: 443-446.
15. 15. Giulivi, C., R. E. Pacifici, and K. J. Davies. 1994. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch. Biochem. Biophys. 311: 329-341.
16. 16. Glenney, J. R. 1986. Antibody probing on Western blots have been stained with india ink. Anal. Biochem. 156: 315-318.
17. 17. Gotz, M. E., G. Kunig, P. Riederer, and M. B. Youdim. 1994. Oxidative stress: Free radical production in neural degeneration. Pharmacol. Ther. 63: 37-122.
18. 18. Harris, M. E., K. Hensley, D. A. Butterfield, R. A. Leedle, and J. M. Carney. 1995. Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta-pep tide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131: 193-202.
19. 19. Hemmer, W., and T. Walliman. 1993. Functional aspects of creatine kinase in brain. Dev. Neurosci. 15: 249-260.
20. 20. Hensley, K., J. M. Carney, M. P. Mattson, M. V. Aksenova, M. E. Harris, J. F. Wu, R. A. Floyd, and D. A. Butterfield. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 3270-3274.
21. 21. Hensley, K., N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, P. Gabbita, J. Wu, J. Carney, M. Lowell, W. R. Markesbery, and D. A. Butterfield. 1995. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65: 2146-2156.
22. 22. Holtzman, D., M. Tsuji, T. Wallimann, and W. Hemmer. 1993. Functional maturation of creatine kinase. Dev. Neurosci. 15: 261-270.
23. 23. Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42: 1097-1105.
24. 24. Kuzhikandathil, E. V., and G. R. Molloy. 1994. Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase. J. Neurosci. Res. 39: 70-72.
25. 25. Ledesma, M. D., P. Bonay, C. Colaco, and J. Avila. 1994. Analyses of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 269: 21614-21619.
26. 26. Lim, L., C. Hall, T. Leung, L. Mahadevan, and S. Whatley. 1983. Neuron-specific enolase and creatine phosphokinase are protein components of rat brain synaptic plasma membranes. J. Neurochem. 41: 177-1182.
27. 27. Lovell, M. A., W. D. Ehmann, S. M. Butler, and W. R. Markesbery. 1995. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601.
28. 28. Manniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. 29. Manos, P., and G. K. Bryan. 1993. Cellular and subcellular compartmentation of creatine kinase in brain. Dev. Neurosci. 15: 271-279.
30. 30. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
31. 31. Mecocci, P., U. MacGarvey, and A. E. Kaufman, et al. 1993. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34: 609-616.
32. 32. Mecocci, P., U. MacGarvey, and M. F. Beal. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-751.
33. 33. Mirra, S. S., A. Heyman, and D. McKeel, et al. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
34. 34. Molloy, G. R., C. D. Wilson, P. Benfield, J. de Vellis, and S. Kumar. 1992. Rat brain creatine kinase messenger RNA levels are high in primary cultures of brain astrocytes and low in neurons. J. Neurochem. 9: 1925-1932.
35. 35. Oliver, C. N., P. E. Starke-Reed, E. R. Stadtman, G. J. Liu, J. M. Carney and R. A. Floyd. 1990. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87: 5144-5147.
36. 36. Payne, R. M., and A. W. Strauss. 1994. Developmental expression of sarcomeric and ubiquitous mitochondrial creatine kinase is tissue-specific. Biochim. Biophys. Acta 1219: 33-38.
37. 37. Perry, E. K., C. M. Morris, J. A. Court, A. Cheng, A. F. Fairbairn, I. G. McKeith, D. Irving, A. Brown, and R. H. Perry. 1995. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology. Neuroscience 64: 385-395.
38. 38. Pettegrew, J. W., K. Panchalingam, W. E. Klunk, R. J. McClure, and L. R. Muenz. 1994. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol. Aging 15: 117-132.
39. 39. Roth, G. S., J. A. Joseph, and R. P. Mason. 1995. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18: 203-206.
40. 40. Schlegel, J., B. Zurbriggen, J. Wegman, N. Wyss, H. M. Eppenberger, and T. Wallimann. 1988. Native mitochondrial creatine kinase forms octameric structures. I. Isolation of two interconvertible mitochondrial creatine kinase forms, dimeric and octameric mitochondrial creatine kinase: Characterization, localization and structure-function relationships. J. Biol. Chem. 32: 16942-16953.
41. 41. Smith, C. D., J. M. Carney, P. E. Starke-Reed, et al. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540-10543.
42. 42. Smith, M. A., L. M. Sayre, V. M. Monnier, and G. Perry. 1995a. Radical ageing in Alzheimer's disease. Trends Neurosci. 18: 172-176.
43. 43. Smith, M. A., M. Rudnicka-Nawrot, P. L. Richey, D. Praprotnik, P. Mulvihill, C. A. Miller, L. M. Sayre, and G. Perry. 1995b. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J. Neurochem. 64: 2660-2666.
44. 44. Stadtman, E. R., P. E. Starke-Reed, C. N. Oliver, J. M. Carney, and R. A. Floyd. 1992. Protein modification in aging. EXS 62: 64-72.
45. 45. Vitek, M. P., K. Bhattacharya, J. M. Glendening, et al. 1994. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91: 4766-4770.
46. 46. Wallimann, T., T. Schlosser, and H. M. Eppenberger. 1984. Function of M-line-bound creatine kinase as intramyofibrillar ATP regenerator and the receiving end of the phosphorylcreatine shuttle in muscle. J. Biol. Chem. 259: 5238-5246.
47. 47. Wallimann, T., D. Walzthony, G. Wegmann, H. Moser, H. M. Eppenberger, and F. J. Barrantes. 1985. Subcellular localization of creatine kinase in Torpedo electrocytes: Association with acetylcholine receptor-rich membranes. J. Cell Biol. 100: 1063-1072.
48. 48. Yan, S. D., X. Chen, A-M. Schmidt, et al. 1994. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA 91: 7787-7791.
49. 49. Zilles, K., M. Qu, A. Schleicher, M. Schroeter, M. Kramer, and O. W. Witte. 1995. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts. Arzneim. -Forsch. 45: 361-366.
50. 50. Zolotarjova, N., C. Ho, R. L. Mellgren, A. Askari, and W. H. Huang. 1994. Different sensitivities of native and oxidized forms of Na+/K(+)-ATPase to intracellular proteinases. Biochim. Biophys. Acta 1192: 125-131.